Mediclin (MED.DE) Osake Kurssi
Mediclin Kurssi
Liikevaihto on kasvanut 3,9 % vuodessa viimeisten 19 vuoden aikana 784,49 M EUR:een. Osakekohtainen tulos on kasvanut 6,3 % vuodessa viimeisten 18 vuoden aikana. Mediclinn nettomarginaali on nyt 3,2 %, noussut 0,2 %:sta muutama vuosi sitten. Mediclinn osinkotuotto on tällä hetkellä noin 0,78 %. Jakosuhde on noin 7 % tuloksesta. Analyytikoiden mediaanitavoitehinta on 5,87 EUR, eli yli nykyhintaa 13,9 %. 5 analyytikosta 4 suosittaa ostoa — kokonaiskonsensus on Osta.
Mediclin osakekurssi
Mediclin liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Mediclin -osakkeesta
The business model of Mediclin AG, a leading healthcare provider, revolves around offering a diverse range of medical services and high-quality patient care. With a focus on providing acute care, rehabilitation, and post-acute care, Mediclin AG operates a network of clinics and hospitals across Germany. Its services include specialized medical treatments, innovative therapies, and comprehensive aftercare programs. By constantly striving for medical excellence and employing experienced healthcare professionals, Mediclin AG aims to deliver optimal outcomes for patients. This company's commitment to delivering superior healthcare services has made it a trusted and reliable choice for individuals seeking top-notch medical care in Germany.
Mediclin AG is primarily active in the healthcare industry.
The main competitors of Mediclin AG in the market include big players like Fresenius SE & Co. KGaA, RHÖN-KLINIKUM AG, and Asklepios Kliniken GmbH & Co. KGaA.
Mediclin AG is a renowned healthcare company based in Germany. With a rich history spanning several decades, Mediclin AG has established itself as a leading provider of medical services and rehabilitation facilities. The company focuses on offering high-quality patient care through a network of clinics, acute care hospitals, and outpatient facilities across the country. Mediclin AG is committed to delivering comprehensive healthcare solutions, encompassing various specialties and treatment options. Their dedication to innovation, expertise, and a patient-centered approach has positioned Mediclin AG as a trusted name in the healthcare industry. Continually evolving and adapting to meet the changing needs of the society, Mediclin AG remains dedicated to improving the overall well-being of individuals by delivering exceptional medical care.
Mediclin AG has achieved several significant milestones in its journey. With a strong focus on providing excellent healthcare services, the company has expanded its network and gained recognition in the industry. Mediclin AG has successfully established state-of-the-art medical facilities, attracting renowned doctors and specialists. Through strategic partnerships and acquisitions, Mediclin AG has enhanced its service offerings and geographical presence. The company's commitment to patient care, innovative treatments, and continuous improvement has earned it a reputable position in the healthcare sector. These milestones have propelled Mediclin AG towards further growth and success in delivering high-quality healthcare services to patients.
Mediclin AG is primarily present in Germany.
Mediclin AG represents a set of core values and a corporate philosophy focused on providing high-quality healthcare services. With a strong emphasis on patient-centric care, Mediclin AG aims to prioritize the well-being and satisfaction of patients. The company strives to deliver excellent medical outcomes by continuously investing in cutting-edge technology and medical expertise. Medical professionalism, integrity, and ethical conduct are central to Mediclin AG's approach, ensuring that patients receive reliable and trustworthy healthcare services. By promoting collaboration among medical professionals and fostering a supportive environment, Mediclin AG aims to create a positive and healing experience for all patients.
Analyytikot asettavat tällä hetkellä Mediclin-osakkeelle keskimääräisen tavoitehinnan 5,87 EUR (mediaani: 5,87 EUR), mikä merkitsee +13,9 % viimeisimpään hintaan verrattuna. Konsensus perustuu 5 analyytikkoarvioon.
5 analyytikkoa arvioi tällä hetkellä Mediclin-osaketta: 4 suosittaa ostoa, 1 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Mediclin-yhtiöltä 824,00 M EUR liikevaihtoa ja 0,79 EUR osakekohtaista tulosta.
Mediclin-osake (MED.DE) on listattuna 7 pörssissä, muun muassa: London (0NDG.L), SIX (Zürich) (MEDCHF.SW), XETRA (MED.DE), Frankfurt (MED.F), München (MED.MU), Düsseldorf (MED.DU), Hamburg (MED.HM).
The Mediclin AG is a company in the healthcare sector that offers various services. The company's headquarters is located in Offenburg and it has clinics, rehabilitation facilities, and nursing homes throughout Germany. The company's divisions include acute hospitals, rehabilitation, post-acute medicine, nursing, and outpatient care. Acute hospitals treat patients with acute illnesses and injuries. The rehabilitation and post-acute medicine departments specialize in helping patients recover after accidents or surgeries. The nursing departments are responsible for caring for older or dependent people. The outpatient services offer various medical services that are provided outside of a hospital setting. Among the products offered by the company are check-up programs in which patients are examined for their health condition. In addition, the company also offers various weight reduction and personal development programs. Additionally, the company offers a variety of therapy services such as physiotherapy, occupational therapy, and speech therapy. The goal of Mediclin AG is to be a holistic healthcare provider that helps people stay healthy and fit on all levels. This means that the company not only offers medical services, but also is active on a psychological and social level. Another business field of the company is research and development. Mediclin AG is involved in various research projects aimed at improving medical care. The company works closely with universities and other research institutes to develop new and innovative methods and technologies. Mediclin AG is a listed company and is listed on the Frankfurt Stock Exchange. The company has a solid financial structure and is able to invest in growth and innovation to increase its competitiveness. Overall, Mediclin AG offers a variety of medical services and products to help people lead healthier lives on many levels. The company follows a comprehensive strategy that ranges from research and development to patient care and is continuously focused on innovation and renewal. Mediclin AG strives to be a reliable and trustworthy partner to its customers in their search for health and well-being.
odotettu liikevaihto Mediclin on 824,00 M EUR. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Mediclin on 37,60 M EUR. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Mediclin:n hinta-voitto-suhde (P/E) on tällä hetkellä 6,51. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Mediclin-osakkeen arvostusta.
Mediclin:n hinta-myynti-suhde (P/S) on tällä hetkellä 0,30. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Mediclin-osakkeen arvostuskennuslukuna.
Mediclin:n Eulpool-laatuscore on 2/10.
Mediclin:n ISIN on DE0006595101. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Mediclin:n WKN on 659510. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Mediclin:n ticker on MED.DE. Tämä pörssinoteeraus käytetään Mediclin-osakkeiden kauppaan pörssissä.
Mediclin osake
Mediclin vertaisryhmä
Mediclin Ticker
Mediclin FIGI
Kaikki tunnusluvut ja syvällinen analyysi Mediclin:sta
Meidän osakeanalyysimme Mediclin-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Mediclin:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: